2025 first_quarter Filing
Q1Lobbying Activities
Issues related to drug pricing and reimbursement for prescription drugs related to "Inflation Reduction Act of 2022" (PL 117-169), Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.
Issues related to drug pricing and reimbursement for prescription drugs related to "Inflation Reduction Act of 2022" (PL 117-169), Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.